Evidence map›Paper›PMID 26447165›Full record

Observational studyClinical cardiology2015

Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery.

Wiktor Kuliczkowski, Joanna Sliwka, Jacek Kaczmarski, Dorota Zysko, Michal Zembala, Damian Steter, Marian Zembala, Seth Fortmann, Victor Serebruany

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Big data modeling to predict platelet usage and minimize wastage in a tertiary care system.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Wiktor KuliczkowskiDepartment of Cardiology, Wroclaw Medical University, Wrocław, Poland.
Joanna SliwkaDepartment of Cardiac Surgery and Transplantation, Silesian Center for Heart Diseases, Zabrze, Poland.
Jacek KaczmarskiDepartment of Cardiac Surgery and Transplantation, Silesian Center for Heart Diseases, Zabrze, Poland.
Dorota ZyskoDepartment of Medical Emergency, Wroclaw Medical University, Wroclaw, Poland.
Michal ZembalaDepartment of Cardiac Surgery and Transplantation, Silesian Center for Heart Diseases, Zabrze, Poland.
Damian SteterDepartment of Cardiac Surgery and Transplantation, Silesian Center for Heart Diseases, Zabrze, Poland.
Marian ZembalaDepartment of Cardiac Surgery and Transplantation, Silesian Center for Heart Diseases, Zabrze, Poland.
Seth FortmannHeartDrug Research Laboratories, Johns Hopkins University, Baltimore, Maryland.
Victor SerebruanyHeartDrug Research Laboratories, Johns Hopkins University, Baltimore, Maryland.
Silesian Center for Heart Disease · PLWroclaw Medical University · PLJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPredicting bleeding events in patients with coronary artery bypass grafting (CABG) represents an unmet medical need that may improve CABG outcomes. HYPOTESIS: To assess the potential link between platelet function testing and bleeding risk in patients undergoing CABG.

methodsPlatelet aggregation and clinical outcomes in 478 patients treated with aspirin and/or clopidogrel were retrospectively analyzed. Platelet activity was assessed prior to CABG with arachidonic acid (ASPI Test), and adenosine diphosphate(ADP Test) utilizing multiple-electrode aggregometry.

resultsIn the study group of 478 patients, mean age was 65.2±15.2 years; 138 were women. The majority of patients (n = 198) underwent on-pump surgery, with 162 undergoing off-pump and 30 undergoing minimally invasive surgery. Forty-eight patients received artificial valve implantation alone, and 40 received valve implantation in combination with CABG. The analysis of the entire pool revealed that an ASPI test value <407 area under curve per minute (AUC*min) may be useful in predicting postoperative drainage. In CABG patients only, an ASPI test value <271 AUC*min predicted the need for red blood cell concentrate transfusion following surgery. In patients who stopped clopidogrel for up to 5 days before surgery, the ADP test failed to exhibit prognostic utility for predicting bleeding risk.

conclusionsIn patients undergoing heart surgery, an ASPI test value <407 AUC*min may predict higher postoperative drainage, whereas <271 AUC*min may be linked to postoperative use of red blood cell concentrate.

Indexed as

Blood Loss, SurgicalPlatelet Function TestsAdultAgedAged, 80 and overArea Under CurveAspirinCardiopulmonary BypassClopidogrelCoronary Artery BypassCoronary Artery Bypass, Off-PumpDrug Administration ScheduleDrug Therapy, CombinationErythrocyte TransfusionFemaleHeart Valve Prosthesis ImplantationAspirinClopidogrelPlatelet Aggregation InhibitorsTiclopidine

Identifiers

PMID26447165
PMCPMC6490720
OpenAlexW2177324307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.